Halftime Report Panelist

Crypto Analyst, CoinDesk
· tracked since Aug 2026
Calls
2
Win Rate
100.0%
return
+5.1%
Calls 2 1 Posts tracked · 0.0/day
Calls
7d 0
30d 0
90d 2
Win Rate 100% Long 2 Short 0
Win Rate
7d 100%
30d 100%
90d
Average Return +5.1% Long Return +5.1% Short Return -
Average Return
7d +9.7%
30d +10.2%
90d
Visual Insights Log in to see more
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Aug 04
$477.93
+7.1%
New purchase as healthcare allocation increases.
Vertex was just purchased as the healthcare weighting was increased to 11.7%, reflecting a conviction that healthcare exposure should continue to rise.
Pharma & Biotech
Long
Aug 04
$1118.45
+3.1%
Cheap valuation, dominant obesity franchise growth.
Eli Lilly has cheapened from its peak (P/E down from 50x to low 30s), is expected to deliver >30% revenue growth and 50% growth in its dominant obesity platform, and upcoming drug approvals could catalyze further upside.
GLP-1 / Obesity
Showing 2 of 2 calls · sorted by mentions

Halftime Report Panelist has 2 trade ideas tracked on Buzzberg across 2 tickers since August 2026. Most covered: LLY, VRTX.

Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology